Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Moderna races to create norovirus vaccines
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Trump administration delays funding to cancer research
*please scroll down for all the latest news*
